10.1021/jm980728e
The study "Synthesis and Antiviral Activity of Ethidium-Arginine Conjugates Directed Against the TAR RNA of HIV-1" investigates the design and biological evaluation of ethidium-arginine conjugates targeting the TAR RNA of HIV-1 to inhibit viral replication. The researchers synthesized six ethidium derivatives with arginine side chains, aiming to disrupt the interaction between the Tat protein and TAR RNA. These conjugates were evaluated for their anti-HIV-1 activity in infected CEM-SS, MT4, and PBMC cells. Compounds 17 and 20 exhibited significant antiviral activity at micromolar concentrations without toxicity. The most active compound, 20, showed strong binding to TAR RNA, as evidenced by melting temperature studies and RNase footprinting experiments. Molecular modeling suggested that the ethidium moiety of compound 20 intercalates near the A17 residue, while the arginine side chain occupies the pyrimidine bulge, providing insights into the mechanism of action and potential for further development of HIV-1 inhibitors.
10.1016/S0040-4039(03)00025-X
The research focuses on the synthesis and properties of ethidium nucleosides and their acyclic analogs. The purpose of this study was to prepare ethidium nucleosides that could potentially be used as building blocks for oligonucleotide synthesis, leveraging ethidium's ability to intercalate between DNA base pairs and its fluorescence properties. The researchers synthesized protected ethidium nucleosides, including 8-(3',5'-di-O-benzoyl-2'-deoxy-D-ribofuranosyl)-3-acetamido-5-ethyl-6-phenylphenanthridinium (5), 8-(3',5'-di-O-acetyl-2'-deoxy-D-ribofuranosyl)-3-acetamido-5-ethyl-6-phenyl-phenanthridinium (6), and the acyclic analog 8-[(3R)-1,3-dihydroxy-4-yl]-acetamido-3-amino-5-ethyl-6-phenyl-phenanthridinium (3). They found that only the acyclic derivative 3 was stable enough for potential use in oligonucleotide synthesis and exhibited absorption and emission properties comparable to underivatized ethidium. Key chemicals used in the synthesis process included 1,3,5-tri-O-acetyl-2-deoxy-D-ribofuranose, 1-chloro-3,5-di-O-benzoyl-2-deoxy-D-ribofuranose, 3,5-di-O-benzoyl-2-deoxy-D-ribofuranose, and various reagents for the protection and deprotection of functional groups, as well as coupling agents like HATU/HOAt and DCC/DMAP.